This inventor holds 1 USPTO granted patent. Top assignee: Alliance of Cardiovascular Researches. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Matthias Ilmer: Innovator in Pancreatic Cancer Treatment
Introduction
Matthias Ilmer is a notable inventor based in Munich, Germany. He has made significant contributions to the field of cancer research, particularly in the treatment of pancreatic cancer. His innovative approach focuses on the priming of pancreatic tumor cells and cancer stem cells to enhance the effectiveness of cancer therapies.
Latest Patents
Matthias Ilmer holds a patent titled "Priming of pancreatic tumor cells and cancer stem cells to TRAIL-induced apoptosis." This invention relates to compositions and methods for the treatment of pancreatic cancer. Specifically, it involves the use of JNK inhibition in conjunction with TRAIL administration to selectively suppress cancer stem cells. This innovative method aims to improve treatment outcomes for patients suffering from this aggressive form of cancer. He has 1 patent to his name.
Career Highlights
Matthias Ilmer is currently associated with the Alliance of Cardiovascular Researches, where he continues to work on groundbreaking research in cancer treatment. His dedication to advancing medical science has positioned him as a key figure in the field.
Collaborations
Throughout his career, Matthias has collaborated with esteemed colleagues, including Eckhard U Alt and Alejandro Recio Boiles. These partnerships have fostered a collaborative environment that enhances the potential for innovative breakthroughs in cancer research.
Conclusion
Matthias Ilmer's work in pancreatic cancer treatment exemplifies the impact of innovative thinking in medical research. His contributions are paving the way for more effective therapies, ultimately benefiting patients in need.